<!DOCTYPE html>
<html lang="en" dir="ltr">

<head>
  <title>IgAN Patient Case - Discover Mark's Kidney Disease Journey</title>
  <meta name="description" content="Learn about Mark’s journey with IgAN, a progressive kidney disease, and how certain kidney lesions can influence his risk of disease progression">
  {{> ../templates/header }}
  <link href="../styles.bundle.css" rel="stylesheet" type="text/css">
</head>

<body>
  <!-- Google Tag Manager (noscript) -->
  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WZLFQZR3" height="0" width="0"
      style="display:none;visibility:hidden"></iframe></noscript>
  <!-- End Google Tag Manager (noscript) -->
  <main class="wrapper" data-page-id="pat-profile-mark" data-path-level="2">

    {{> ../templates/nav }}
    {{> ../templates/interstitial }}

    <div class="progress-dots-container"></div>

    {{> ../templates/mestc-score-modal }}

    <div class="modal" data-modal-id="igan-prediction">
      <div class="modal-inner">
        <img src="./assets/images/modal-close.svg" class="modal-close update-path" alt="Close X icon" />

        <h1 class="modal-big-header">国际 lgA肾病预测工具<sup>1,2</sup></h1>
        <h2 class="modal-header">国际 IgA肾病预测工具的开发旨在帮助肾病科医生评估患者进展为 ESKD 或 eGFR下降 50% 的风险</h2>

        <p class="bold purple">用于风险评估的因素：</p>

        <ul class="bullet-list">
          <li><span class="bullet">&bull;</span><span>年龄</span></li>
          <li><span class="bullet">&bull;</span><span>种族</span></li>
          <li><span class="bullet">&bull;</span><span>eGFR</span></li>
          <li><span class="bullet">&bull;</span><span>血压</span></li>
          <li><span class="bullet">&bull;</span><span>蛋白尿</span></li>
          <li><span class="bullet">&bull;</span><span>是否存在MEST 病变</span></li>
          <li><span class="bullet">&bull;</span><span>ACE 抑制剂或 ARB 使用情况</span></li>
          <li><span class="bullet">&bull;</span><span>免疫抑制剂使用情况</span></li>
        </ul>

        <p class="text">尽管新月体已被证实会增加 IgA肾病的进展风险，但预测工具并未纳入该因素。<sup>1-3</sup></span></p>
        <p class="text">为全面评估患者风险，HCP 可能需要考虑额外的疾病特征，例如新月体的存在。</p>

        <p class="bold purple">继续了解新月体如何影响 IgA肾病的进展</p>

        <div class="footnotes">
          <p>ACE：血管紧张素转换酶；ARB：血管紧张素受体拮抗剂；<br>
            eGFR：估算肾小球滤过率；HCP：医疗专业人员；<br>
            MEST：系膜细胞增生（M）、毛细血管内皮细胞增生（E）、节段性硬化（S）、肾小管萎缩和间质纤维化（T）。</p>
          <p><span class="bold">参考文献: 1.</span> Barbour SJ, et al. <em>JAMA Intern Med</em>. 2019;179(7):942-952.
            <span class="bold">2.</span> Barbour SJ, et al. <em>Kidney Int</em>. 2022;102(1):160-172. <span
              class="bold">3.</span> Du Y, et al. <em>Front Med (Lausanne)</em>. 2022;9:864667.</p>
        </div>
      </div>
    </div>

    <img id="scroll-arrow" class="update-path" src="./assets/images/scroll-arrow.svg" alt="Scroll arrow down" />

    <div id="mark-bio-tray" class="mobile-bio-tray">
      <div id="tray-close">
        <p>活检时基线评估</p>
        <img src="./assets/images/back-arrow.svg" class="update-path arrow" alt="Back arrow"/>
      </div>

      <p class="name">马克（34岁）</p>

      {{> ../templates/mark-bio }}

      <div class="extra-section">
        <p class="extra-footnote">*图像出处：Luis Fernando Arias-Restrepo博士，安第斯大学，麦德林，哥伦比亚经许可使用，网址：<a class="format-url link-color" target="_blank"
          href="https://kidneypathology.com/English_version/IgA_Nephropathy.html">https://kidneypathology.com/English_version/IgA_Nephropathy.html</a>. Used with permission.
        </p>
    
        <p class="extra-footnote">ACE：血管紧张素转换酶；ARB：血管紧张素II受体阻滞剂；eGFR：估算肾小球滤过率；H&E：苏木精-伊红；MEST-C：系膜细胞增生（M）、毛细血管内皮细胞增生（E）、节段性硬化（S）、肾小管萎缩和间质纤维化（T）、新月体（C）。</p>
      </div>
    </div>

    <!-- //////////////////// SECTION 1 ///////////////////// -->

    <section class="" data-section-id="1" data-section-name="Mark Patient Information" data-dot-label="走近马克">
      <div class="two-column">

        <div id="left-bio">
          <img src="./assets/images/profiles/mark-profile.png" class="update-path bio-pic" alt="" />
          
          {{> ../templates/mark-bio }}
        </div>

        <div class="right-side">
          <img src="./assets/images/profiles/mark-profile.png" class="update-path bio-pic conditional-render" alt=""/>
          <p class="name conditional-render">马克（34岁）</p>

          <h1 class="sect-1-header">马克是一位34岁的跑步爱好者，因工作新职位经常出差。</h1>

          <p class="bold">在过去的两周里，马克发现自己的尿液中偶尔有血且呈泡沫状。</span></p>

          <ul class="bullet-list">
            <li><span class="bullet">&bull;</span><span>血液检测显示其肌酐水平升高，为1.7 mg/dL</span></li>
            <li><span class="bullet">&bull;</span><span>马克被转诊至肾病科医生处，进一步的检查显示其蛋白尿水平为2.5 g/d，并患有3a期慢性肾脏病</span></li>
          </ul>

          <div class="divider"></div>

          <h4 class="purple align-center">根据以上结果，他的肾病科医生进行了肾脏活检，确诊了 lgAN，<br>
            并显示出系膜细胞增生、毛细血管内皮细胞增生以及 15% 的肾小球新月体形成。</h4>

          <p class="direction bold align-center tablet-desktop-only">点击下方轮播图中的箭头，查看莎拉的基线特征</p>
        </div>

      </div>
    </section>

    <div class="temp-section mobile-only">
      <p class="direction bold align-center">滑动下方轮播图，查看马克的基线特征</p>
    </div>

    <!-- //////////////////// SECTION 2 ///////////////////// -->

    <section class="" data-section-id="2" data-section-name="Mark Demographic and Information Carousel" data-dot-label="基线特征">
      <div class="owl-carousel">
        <div class="carousel-block" id="mark-block-1">
          <h3 class="label">活检时年龄</h3>
          <h4 class="characteristic">34 岁</h4>

          <ul class="bullet-list">
            <li><span class="bullet">&bull;</span><span>IgA肾病主要在 20-40 岁的成年人中确诊<sup>1,2</sup></span></li>
            <li><span class="bullet">&bull;</span><span>临床表现和疾病进展会因患者确诊时的年龄不同而产生差异<sup>3</sup></span></li>
          </ul>

          <div class="footnotes">
            <p><span class="bold">参考文献：1.</span> Caster DJ, et al. <em>Kidney Int Rep</em>. 2023;8(9):1792-1800. <span
                class="bold">2.</span> Lai KN, et al. <em>Nat Rev Dis Primers</em>. 2016;2:16001. <span
                class="bold">3.</span> Gutierrez E, et al. <em>Nephrol Dial Transplant</em>. 2018;33:472-477.</p>
          </div>
        </div>

        <div class="carousel-block" id="mark-block-2">
          <h3 class="label">种族</h3>
          <h4 class="characteristic">白人</h4>

          <ul class="bullet-list">
            <li><span class="bullet">&bull;</span><span>IgA肾病的发病率和进展可能因地区和种族而异<sup>1</sup></span></li>
            <ul>
              <li><span class="bullet">&ndash;</span><span>美国年发病率约为每 10 万人 1.29 例，<br>
                  欧洲约为每 10 万人 0.76 例，<br>
                  日本约为每 10 万人 4.2例<sup>2-4</sup></span></span></li>
            </ul>
          </ul>

          <div class="footnotes">
            <p><span class="bold">参考文献：1.</span> Yeo SC, et al. <em>Nephrology (Carlton)</em>.
              2019;24(9):885-895. <span class="bold">2.</span> Kwon CS, et al. <em>J Health Econ Outcomes Res</em>.
              2021;8(2):36-45. <span class="bold">3.</span> Willey C, et al. <em>Nephrol Dial Transplant</em>.
              2023;38(10):2340-2349. <span class="bold">4.</span> Kiryluk K, et al. <em>Kidney360</em>.
              2023;4(8):1112-1122.</p>
          </div>
        </div>

        <div class="carousel-block" id="mark-block-3">
          <h3 class="label">活检时eGFR</h3>
          <h4 class="characteristic">54 mL/min/<br class="mobile-only"/>1.73 m<sup>2</sup></h4>

          <ul class="bullet-list">
            <li><span class="bullet">&bull;</span><span>马克的 eGFR 表明他处于 CKD 3a 期，这意味着他的肾脏存在一定程度的损伤，导致肾功能轻度至中度下降</span></li>
            <li><span class="bullet">&bull;</span><span> eGFR 下降是 IgAN 进展的明确危险因素。<br>
              eGFR 降低与CKD 进展和死亡风险密切相关<sup>1,2</sup></span></li>
          </ul>

          <div class="footnotes">
            <p>CKD：慢性肾脏病；eGFR：估算肾小球滤过率。</p>
            <p><span class="bold">参考文献：1.</span> Coresh J, et al. <em>JAMA</em>. 2014;311(24):2518-2531. <span class="bold">2.</span> KDIGO. <em>Kidney Int</em>. 2021;100:S1-S276.</p>
          </div>
        </div>

        <div class="carousel-block" id="mark-block-4">
          <h3 class="label">活检时血压</h3>
          <h4 class="characteristic">140/80 mm Hg</h4>

          <ul class="bullet-list">
            <li><span class="bullet">&bull;</span><span>活检时发现马克的血压偏高</span></li>
            <li><span class="bullet">&bull;</span><span>研究表明，高血压是 IgA肾病在确诊时进展的临床预测因素<sup>1</sup></span></li>
            <li><span class="bullet">&bull;</span><span>降低高血压可降低进展为肾衰竭的风险<sup>2</sup></span></li>
          </ul>

          <div class="footnotes">
            <p><span class="bold">参考文献：1.</span> Maixnerova D, et al. <em>J Nephrol</em>. 2016;29(4):535-541.
              <span class="bold">2.</span> KDIGO. <em>Kidney Int</em>. 2021;100:S1-S276.</p>
          </div>
        </div>

        <div class="carousel-block" id="mark-block-5">
          <h3 class="label">活检时蛋白尿</h3>
          <h4 class="characteristic">2.5 g/d</h4>

          <ul class="bullet-list">
            <li><span class="bullet">&bull;</span><span>活检时马克的蛋白尿水平升高</span></li>
            <li><span class="bullet">&bull;</span><span>蛋白尿是公认的预后标志物，与长期肾脏结局相关，包括eGFR下降和ESKD进展<sup>1,2</sup></span></li>
            <li><span class="bullet">&bull;</span><span>蛋白尿减少与血清肌酐倍增、ESKD及死亡风险呈负相关<sup>2,3</sup></span></li>
          </ul>

          <div class="footnotes">
            <p>eGFR：估算肾小球滤过率；ESKD：终末期肾病。</p>
            <p><span class="bold">参考文献：1.</span> KDIGO. <em>Kidney Int</em>. 2021;100:S1-S276. <span
                class="bold">2.</span> Thompson A, et al. <em>Clin J Am Soc Nephrol</em>. 2019;14(3):469-481. <span
                class="bold">3.</span> Inker L, et al. <em>Am J Kidney Dis</em>. 2016;68(3):392-401.</p>
          </div>
        </div>

        <div class="carousel-block" id="mark-block-6">
          <h3 class="label">活检时ACE<span class="lower">i</span>/ARB使用情况</h3>
          <h4 class="characteristic">未使用</h4>

          <p>ACEi/ARB是指南推荐的支持治疗，<br>
            但马克在活检时尚未启动该治疗。<sup>1</sup></p>

          <div class="footnotes">
            <p>ACEi：血管紧张素转换酶抑制剂；ARB：血管紧张素 II 受体拮抗剂。</p>
            <p><span class="bold">参考文献：1.</span> KDIGO. <em>Kidney Int</em>. 2021;100:S1-S276.</p>
          </div>
        </div>

        <div class="carousel-block" id="mark-block-7">
          <h3 class="label">MEST-C 评分</h3>
          <h4 class="characteristic">M1 E1 S0 T0 C1</h4>

          <p>马克的活检采用了牛津分型，即MEST-C评分。其活检结果显示：超过 50% 的肾小球出现系膜细胞增生，伴随毛细血管内皮细胞增生，15% 的肾小球出现新月体，但未见节段性肾小球硬化以及肾小管萎缩/间质纤维化。</p>
          <p>MEST-C 评分可作为具有价值的早期预后评估工具，在评估疾病进展至ESKD的风险时，应将其纳入考量。<sup>1-3</sup></p>

          <div class="button cta modal-trigger" data-trigger-id="mest-c-score">
            <p>了解更多关于 MEST-C 的信息</p>
          </div>

          <div class="footnotes">
            <p>ESKD：终末期肾病；MEST-C：系膜细胞增生（M）、毛细血管内皮细胞增生（E）、节段性硬化（S）、肾小管萎缩和间质纤维化（T）、新月体（C）。</p>
            <p><span class="bold">参考文献：1.</span> Cattran DC, et al. <em>Kidney Int Rep</em>.
              2023;8(12):2515-2528. <span class="bold">2.</span> Haaskjold YL, et al. <em>BMC Nephrology</em>.
              2022;23:26. <span class="bold">3.</span> Coppo R, et al. <em>Kidney Int</em>. 2014;86(4):828-836.</p>
          </div>
        </div>

        <div class="carousel-block" id="mark-block-8">
          <h3 class="label">活检时或活检前免疫抑制剂使用情况</h3>
          <h4 class="characteristic">未使用</h4>

          <p>免疫抑制治疗对IgA肾病患者的临床获益尚未明确，<br>
            经评估风险与获益可接受时，<br>
            特定患者人群可考虑采用。<sup>1</sup></p>

          <div class="footnotes">
            <p><span class="bold">参考文献：1.</span> KDIGO. <em>Kidney Int</em>. 2021;100:S1-S276.</p>
          </div>
        </div>
      </div>

    </section>

    <div class="temp-section">
      <div class="footnotes">
        <p>*图像出处： Luis Fernando Arias-Restrepo博士，安第斯大学，麦德林，哥伦比亚查阅网址：<a href="https://kidneypathology.com/English_version/IgA_Nephropathy.html" class="format-url link-color">https://kidneypathology.com/English_version/IgA_Nephropathy.html</a>. 经许可使用。
        </p>
    
        <p>ACE：血管紧张素转换酶；ARB：血管紧张素 Ⅱ 受体阻滞剂；CKD：慢性肾脏病；eGFR：估算肾小球滤过率；<br>
        H&E：苏木精-伊红；MEST-C：系膜细胞增生（M）、毛细血管内皮细胞增生（E）、节段性硬化（S）、肾小管萎缩和间质纤维化（T）、新月体（C）。</p>
      </div>

      <img class="tablet-only update-path mobile-bio-trigger" id="mobile-bio-trigger" data-tray-id="mark-bio-tray" src="./assets/images/profiles/mobile-bio-btn.png" alt="Baseline Assessment trigger button"/>
    </div>

    <section class="" data-section-id="3" data-section-name="Mark Impact of Crescents on IgAN Progression" data-dot-label="组织病理学改变">
      <div class="flex-header">
        <img src="./assets/images/profiles/mark-profile.png" class="desktop-only update-path bio-pic" alt="" />

        <div>
          <h1 class="pat-header">新月体对 IgA肾病进展的影响</h1>
          <p class="desc-text">国际 IgA肾病预测工具显示，马克在5年后有12%的进展风险。
            然而，他的活检结果显示存在新月体，尽管新月体未被纳入风险预测模型，
            但与不良预后和肾功能更快下降有关。<sup>1-3,a</sup></p>
          <div class="gap-10"></div>
          <p class="desc-text">鉴于马克面临的风险，他开始接受支持治疗。</p>

          <a href="https://qxmd.com/calculate/calculator_499/international-igan-prediction-tool-at-biopsy-adults"
            target="_blank" class="button cta" id="sect-3-tool-exit">
            <p>查看国际 lgA肾病 预测工具</p>
            <img src="./assets/images/external-icon-white.svg" class="update-path" alt="External link icon" />
          </a>
          <div class="button cta modal-trigger" id="sect-3-learn-more" data-trigger-id="igan-prediction">
            <p>了解更多关于国际 IgA肾病预测工具中用于评估风险的因素</p>
          </div>
        </div>
      </div>

      <div class="content-lower">

        <div class="divider"></div>

        <h3 class="graph-header">肾脏病理特征的变化</h3>
        <p class="direction">滑动查看组织病理学特征如何随时间变化，并影响肾脏存活率。</p>

        <div class="images-container">
          <div class="left-side">
            <div class="text-bubble visible" id="section-3-state-1">
              <p>马克确诊时的活检显示系膜细胞增生、毛细血管内皮细胞增生以及新月体形成。新月体形成用下图黑色箭<span class="nowrap">头标出<sup>b</sup>。</span></p>

              <div class="gap-10"></div>

              <img src="./assets/images/profiles/mark/stain.png" class="stain update-path"
                alt="PAS staining showing: Mark’s biopsy at diagnosis showed mesangial hypercellularity, endocapillary hypercellularity, and crescents. Crescent formation indicated by a black arrow." />

              <div class="gap-10"></div>

              <p>图像经授权使用*</p>
            </div>

            <div class="text-bubble" id="section-3-state-2">
              <p>细胞继续在毛细血管和<br>
                系膜中聚集，<br>
                炎症细胞浸润新月体。</p>
            </div>

            <div class="text-bubble" id="section-3-state-3">
              <p>系膜区沉积过量 ECM，<br>
                新月体弥漫性累及整个肾小球，<br>
                肾小管开始出现萎缩迹象。</p>
            </div>

            <div class="text-bubble" id="section-3-state-4">
              <p>细胞持续在毛细血管和系膜区聚集，炎症细胞不断浸润新月体，肾小管萎缩程度加重。</p>
            </div>
          </div>

          <div class="right-side">
            <div class="graphic-container">
              <img src="./assets/images/profiles/mark/graphic-1.png" id="section-3-state-1" class="update-path graphic visible" 
                alt="Detailed glomerulus structure showing crescent formation, mesangial cells and immune cells" />
              <img src="./assets/images/profiles/mark/graphic-2.png" id="section-3-state-2" class="update-path graphic"
                alt="Detailed kidney structure showing crescent formation, mesangial cells and immune cells" />
              <img src="./assets/images/profiles/mark/graphic-3.png" id="section-3-state-3" class="update-path graphic"
                alt="Glomerulus showing crescent formation, mesangial cells, and immune cells" />
              <img src="./assets/images/profiles/mark/graphic-4.png" id="section-3-state-4" class="update-path graphic"
                alt="Glomerulus showing crescent formation, immune cells, and tubular atrophy" />

              <div class="histo-tag group-1" id="tag-1">
                <p>红细胞</p>
                <img src="./assets/images/plus-icon.svg" alt="" class="plus update-path"/>
                <img src="./assets/images/x-icon.svg" alt="" class="close update-path"/>
              </div>
              <div class="histo-tag group-1" id="tag-2">
                <p>新月体（上皮细胞和免疫细胞）</p>
                <img src="./assets/images/plus-icon.svg" alt="" class="plus update-path"/>
                <img src="./assets/images/x-icon.svg" alt="" class="close update-path"/>
              </div>
              <div class="histo-tag group-1" id="tag-3">
                <p>蛋白质</p>
                <img src="./assets/images/plus-icon.svg" alt="" class="plus update-path"/>
                <img src="./assets/images/x-icon.svg" alt="" class="close update-path"/>
              </div>
              <div class="histo-tag group-1" id="tag-4">
                <p>ECM</p>
                <img src="./assets/images/plus-icon.svg" alt="" class="plus update-path"/>
                <img src="./assets/images/x-icon.svg" alt="" class="close update-path"/>
              </div>
              <div class="histo-tag group-1" id="tag-5">
                <p>Gd-IgA1 免疫复合物</p>
                  <img src="./assets/images/plus-icon.svg" alt="" class="plus update-path"/>
                  <img src="./assets/images/x-icon.svg" alt="" class="close update-path"/>
              </div>
              <div class="histo-tag group-1" id="tag-6">
                <p>免疫细胞</p>
                <img src="./assets/images/plus-icon.svg" alt="" class="plus update-path"/>
                <img src="./assets/images/x-icon.svg" alt="" class="close update-path"/>
              </div>
              <div class="histo-tag group-1" id="tag-7">
                <p>系膜细胞​</p>
                  <img src="./assets/images/plus-icon.svg" alt="" class="plus update-path"/>
                  <img src="./assets/images/x-icon.svg" alt="" class="close update-path"/>
              </div>
              <div class="histo-tag group-3 hidden" id="tag-8">
                <p>肾小管萎缩</p>
                  <img src="./assets/images/plus-icon.svg" alt="" class="plus update-path"/>
                  <img src="./assets/images/x-icon.svg" alt="" class="close update-path"/>
              </div>
            </div>

            <div class="slider-container conditional-slider-upper">
                <img src="./assets/images/profiles/over-time-slider-1.svg" id="section-3-state-1"
                  class="update-path slider-upper slider visible" alt="Slider shown at biopsy stage">
                <img src="./assets/images/profiles/over-time-slider-2.svg" id="section-3-state-2"
                  class="update-path slider-upper slider" alt="Slider shown at 2 years">
                <img src="./assets/images/profiles/over-time-slider-3.svg" id="section-3-state-3"
                  class="update-path slider-upper slider" alt="Slider shown at 4 years">
                <img src="./assets/images/profiles/over-time-slider-4.svg" id="section-3-state-4"
                  class="update-path slider-upper slider" alt="Slider shown at 6 years">

                <input type="range" class="range-slider" id="s3-upper" name="s3-upper" min="1" max="4" value="1" step="1" />
            </div>
          </div>
        </div>

        <div class="mobile-only slider-container">
          <img src="./assets/images/profiles/over-time-slider-1-mobile.png" id="section-3-state-1"
            class="update-path mobile-graph slider-upper slider visible" alt="Slider shown at biopsy stage">
          <img src="./assets/images/profiles/over-time-slider-2-mobile.png" id="section-3-state-2"
            class="update-path mobile-graph slider-upper slider" alt="Slider shown at 2 years">
          <img src="./assets/images/profiles/over-time-slider-3-mobile.png" id="section-3-state-3"
            class="update-path mobile-graph slider-upper slider" alt="Slider shown at 4 years">
          <img src="./assets/images/profiles/over-time-slider-4-mobile.png" id="section-3-state-4"
            class="update-path mobile-graph slider-upper slider" alt="Slider shown at 6 years">
            
          <input type="range" class="range-slider" id="s3-mobile" name="s3-mobile" min="1" max="4" value="1" step="1" />
        </div>

        <div class="slider-container conditional-slider-lower">
          <img src="./assets/images/profiles/over-time-slider-1.svg" id="section-3-state-1"
            class="update-path slider-upper graph slider visible" alt="Slider shown at biopsy stage">
          <img src="./assets/images/profiles/over-time-slider-2.svg" id="section-3-state-2"
            class="update-path slider-upper graph slider" alt="Slider shown at 2 years">
          <img src="./assets/images/profiles/over-time-slider-3.svg" id="section-3-state-3"
            class="update-path slider-upper graph slider" alt="Slider shown at 4 years">
          <img src="./assets/images/profiles/over-time-slider-4.svg" id="section-3-state-4"
            class="update-path slider-upper graph slider" alt="Slider shown at 6 years">

          <input type="range" class="range-slider" id="s3-conditional" name="s3-conditional" min="1" max="4" value="1" step="1" />
        </div>

        <div class="graphs-container">
          <div class="left-side">
            <div class="tablet-desktop-only">
              <img src="./assets/images/profiles/mark/pro-over-time-state-1.png" id="section-3-state-1"
                class="update-path graph visible" alt="Graph modeling proteinuria progression over time, starting at biopsy">
              <img src="./assets/images/profiles/mark/pro-over-time-state-2.png" id="section-3-state-2"
                class="update-path graph" alt="Graph showing proteinuria level after two years">
              <img src="./assets/images/profiles/mark/pro-over-time-state-3.png" id="section-3-state-3"
                class="update-path graph" alt="Graph showing proteinuria progression at four years">
              <img src="./assets/images/profiles/mark/pro-over-time-state-4.png" id="section-3-state-4"
                class="update-path graph" alt="Graph showing proteinuria progression at six years">
            </div>
            <div class="mobile-only">
              <img src="./assets/images/profiles/mark/mobile/pro-over-time-state-1-mobile.png" id="section-3-state-1"
                class="update-path mobile-graph graph visible" alt="Graph modeling proteinuria progression over time, starting at biopsy">
              <img src="./assets/images/profiles/mark/mobile/pro-over-time-state-2-mobile.png" id="section-3-state-2"
                class="update-path mobile-graph graph" alt="Graph showing proteinuria level after two years">
              <img src="./assets/images/profiles/mark/mobile/pro-over-time-state-3-mobile.png" id="section-3-state-3"
                class="update-path mobile-graph graph" alt="Graph showing proteinuria progression at four years">
              <img src="./assets/images/profiles/mark/mobile/pro-over-time-state-4-mobile.png" id="section-3-state-4"
                class="update-path mobile-graph graph" alt="Graph showing proteinuria progression at six years">
            </div>
          </div>
          <div class="right-side">
            <div class="tablet-desktop-only">
              <img src="./assets/images/profiles/mark/egfr-over-time-state-1.png" id="section-3-state-1"
                class="update-path graph visible" alt="Graph modeling eGFR decline over time, starting at biopsy">
              <img src="./assets/images/profiles/mark/egfr-over-time-state-2.png" id="section-3-state-2"
                class="update-path graph" alt="Graph showing eGFR after two years">
              <img src="./assets/images/profiles/mark/egfr-over-time-state-3.png" id="section-3-state-3"
                class="update-path graph" alt="Graph showing eGFR after four years">
              <img src="./assets/images/profiles/mark/egfr-over-time-state-4.png" id="section-3-state-4"
                class="update-path graph" alt="Graph showing eGFR after six years">
            </div>
            <div class="mobile-only">
              <img src="./assets/images/profiles/mark/mobile/egfr-over-time-state-1-mobile.png" id="section-3-state-1"
                class="update-path mobile-graph graph visible" alt="Graph modeling eGFR decline over time, starting at biopsy">
              <img src="./assets/images/profiles/mark/mobile/egfr-over-time-state-2-mobile.png" id="section-3-state-2"
                class="update-path mobile-graph graph" alt="Graph showing eGFR after two years">
              <img src="./assets/images/profiles/mark/mobile/egfr-over-time-state-3-mobile.png" id="section-3-state-3"
                class="update-path mobile-graph graph" alt="Graph showing eGFR after four years">
              <img src="./assets/images/profiles/mark/mobile/egfr-over-time-state-4-mobile.png" id="section-3-state-4"
                class="update-path mobile-graph graph" alt="Graph showing eGFR after six years">
            </div>
          </div>
        </div>

        <div class="slider-container">
          <div class="tablet-desktop-only">
            <img src="./assets/images/profiles/over-time-slider-1.svg" id="section-3-state-1"
              class="update-path slider-lower slider visible" alt="Slider shown at biopsy stage">
            <img src="./assets/images/profiles/over-time-slider-2.svg" id="section-3-state-2"
              class="update-path slider-lower slider" alt="Slider shown at 2 years">
            <img src="./assets/images/profiles/over-time-slider-3.svg" id="section-3-state-3"
              class="update-path slider-lower slider" alt="Slider shown at 4 years">
            <img src="./assets/images/profiles/over-time-slider-4.svg" id="section-3-state-4"
              class="update-path slider-lower slider" alt="Slider shown at 6 years">
          </div>
          <div class="mobile-only">
            <img src="./assets/images/profiles/over-time-slider-1-mobile.png" id="section-3-state-1"
              class="update-path mobile-graph slider-lower slider visible" alt="Slider shown at biopsy stage">
            <img src="./assets/images/profiles/over-time-slider-2-mobile.png" id="section-3-state-2"
              class="update-path mobile-graph slider-lower slider" alt="Slider shown at 2 years">
            <img src="./assets/images/profiles/over-time-slider-3-mobile.png" id="section-3-state-3"
              class="update-path mobile-graph slider-lower slider" alt="Slider shown at 4 years">
            <img src="./assets/images/profiles/over-time-slider-4-mobile.png" id="section-3-state-4"
              class="update-path mobile-graph slider-lower slider" alt="Slider shown at 6 years">
          </div>

          <input type="range" class="range-slider" id="s3-lower" name="s3-lower" min="1" max="4" value="1" step="1" />
        </div>
      </div>

      <h4 class="bottom-subhead">当前 KDIGO 指南不建议在非糖尿病的 IgA肾病患者中使用 SGLT2i ，因其疗效和安全性数据还有待完善。<br>
        虚拟患者病例采用的治疗依据当前治疗指南制定。<sup>4</sup></h4>

      <div class="footnotes">
        <p>上图仅供参考，旨在说明 IgA肾病期间可能出现的潜在组织病理学变化，而并非旨在提供这些变化进展的具体信息，也不用于指导治疗决策。<br>
          蛋白尿的变化和 eGFR 的变化均根据临床试验和队列研究结果趋势设定。<sup>5-8</sup></p>
        <p>图片出处：Luis Fernando Arias-Restrepo 博士，安第斯大学，麦德林，哥伦比亚。通过 <a href="https://kidneypathology.com/English_version/IgA_Nephropathy.html" class="format-url link-color">https://kidneypathology.com/English_version/IgA_Nephropathy.html</a>. 获取，经许可使用。
        </p>
        <p><sup>a</sup>预测进展风险是通过国际 IgA肾病预工具计算得出的，定义为 eGFR 下降 50% 或进入 ESKD 的风险。<sup>3</sup></p>
        <p><sup>b</sup>H&E 染色显示系膜细胞增生、毛细血管内皮细胞增生和新月体形成。新月体形成用黑色箭头标出。单个肾小球可能无法全面反映MEST-C评分所有组分。</p>
        <p>eGFR：估算肾小球滤过率；ESKD：终末期肾病；H&E：苏木精-伊红；KDIGO：改善全球肾脏病预后组织；MEST-C：系膜细胞增生（M）、毛细血管内皮细胞增生（E）、节段性硬化（S）、肾小管萎缩和间质纤维化（T）、新月体（C）；SGLT2i：钠 - 葡萄糖协同转运蛋白 2 抑制剂。</p>
        <p><span class="bold">参考文献: 1.</span> Pattrapornpisut P, et al. <em>Am J Kidney Dis</em>.
          2021;78(3):429-441. <span class="bold">2.</span> Cattran DC, et al. <em>Kidney Int Rep</em>.
          2023;8(12):2515-2528. <span class="bold">3.</span> Barbour SJ, et al. <em>JAMA Intern Med</em>.
          2019;179(7):942-952. <span class="bold">4.</span> KDIGO. <em>Kidney Int</em>. 2021;100:S1-S276. <span
            class="bold">5.</span> Pitcher D, et al. <em>Clin J Am Soc Nephrol</em>. 2023;18(6):727-738. <span
            class="bold">6.</span> Faucon AL, et al. <em>Nephrol Dial Transplant</em>. 2024;30:gfae085. <span
            class="bold">7.</span> Rovin BH, et al. <em>Lancet</em>. 2023;402(10417):2077-2090. <span class="nowrap"><span
            class="bold">8.</span> Lafayette R,</span> et al. <em>Lancet</em>. 2023;402:859-870.</p>
      </div>
    </section>

    <section data-section-id="4" class="gray-bg" data-section-name="Mark Impact of Crescents on IgAN Progression 100-month Kidney Survival Rate" data-dot-label="新月体的影响">
      <div class="flex-header">
        <img src="./assets/images/profiles/mark-profile.png" class="desktop-only update-path bio-pic" alt="" />

        <div>
          <h1 class="pat-header">新月体对 IgA肾病进展的影响</h1>
          <p class="desc-text">国际 IgA肾病预测工具显示，马克在 5 年后有 12% 的进展风险。
            然而，他的活检结果显示存在新月体，尽管新月体未被纳入风险预测模型，
            但与不良预后和肾功能更快下降有关<sup>1-3,a</sup>。</p>
          <div class="gap-10"></div>
          <p class="desc-text">鉴于马克面临的风险，他开始接受支持治疗。</p>
        </div>
      </div>

      <div id="content-box">
        <h2>新月体的存在提示急需进行治疗</h2>

        <div class="flex">
          <img src="./assets/images/profiles/mark/crescents-graphic.png" class="graphic update-path"
            alt="Detailed glomerulus structure showing presence of crescents" />

            <ul class="bullet-list">
              <li><span class="bullet">&bull;</span><span>新月体提示因 GBM 破裂引发的活动性肾小球炎症，会导致鲍氏囊腔内细胞和蛋白质堆积<sup>4</sup></span></li>
              <li><span class="bullet">&bull;</span><span>早期新月体或许可逆，但高 C 评分提示肾衰竭进展迅速<sup>5,6</sup></span></li>
            </ul>
        </div>

        <p class="subhead">高 C 评分提示存在活动性肾小球损伤及疾病快速进展<sup>6,7</sup></p>
      </div>

      <div class="footnotes">
        <p><sup>a</sup>预测进展风险是通过国际 IgA肾病预测工具计算得出的，定义为 eGFR 下降 50% 或进入 ESKD 的风险。</p>
        <p>eGFR：估算肾小球滤过率；ESKD：终末期肾病；GBM：肾小球基底膜；<br>
        MEST-C：系膜细胞增生（M）、毛细血管内皮细胞增生（E）、节段性硬化（S）、肾小管萎缩和间质纤维化（T）、新月体（C）</p>
        <p><span class="bold">参考文献: 1.</span> Pattrapornpisut P, et al. <em>Am J Kidney Dis</em>. 2021;78(3):429-441. <span class="bold">2.</span> Cattran DC, et al. <em>Kidney Int Rep</em>. 2023;8(12):2515-2528. <span class="bold">3.</span> Barbour SJ, et al. <em>JAMA Intern Med</em>. 2019;179(7):942-952. <span class="bold">4.</span> Mushafi AA, et al. <em>Front Physiol</em>. 2021;12:724186. <span class="bold">5.</span> Trimarchi H, et al. <em>Kidney Int</em>. 2017;91(5):1014-1021. <span class="bold">6.</span> Shen XH, et al. <em>J Nephrol</em>. 2015;28:441-449. <span class="bold">7.</span> Rodrigues JC, et al. <em>Clin J Am Soc Nephrol</em>. 2017;12:677-686.</p>
      </div>
    </section>

    <section data-section-id="5" class="gray-bg acc-section" data-section-name="Mark Impact of eGFR Decline on Progression to ESKD" data-dot-label="eGFR 下降对疾病进展<br>的影响">

      <div class="acc-header">
        <p>了解更多马克的 eGFR 如何随时间下降的信息</p>
        <img src="./assets/images/acc-arrow.svg" class="update-path acc-arrow" alt=""/>
      </div>

      <div class="acc-content">
        <div class="flex-header">
          <img src="./assets/images/profiles/mark-profile.png" class="desktop-only update-path bio-pic" alt="" />

          <div>
            <h1 class="pat-header">eGFR 下降对疾病进展为肾衰竭的影响</h1>
            <p class="desc-text">根据马克的eGFR下降速度，他可能在10年内进展为肾衰竭。</p>
          </div>
        </div>

        <p class="bold">如果马克的eGFR下降速度稳定下来，这将有助于延缓进展为肾衰竭。</p>
        <p class="direction">点击下方按钮，查看不同eGFR下降速度对进展至肾衰竭的影响。</p>

        <div class="graph-container">
          <div class="desktop-only">
            <img src="./assets/images/profiles/mark/section-5-graph-state-0.png" id="0" class="update-path graph"
              alt="Graph depicting changes in eGFR over time" />
            <img src="./assets/images/profiles/mark/section-5-graph-state-1.png" id="state-3" class="visible update-path graph"
              alt="Graph depicting changes in eGFR over time at a loss of 5 mL/min/1.73 m2 per year" />
            <img src="./assets/images/profiles/mark/section-5-graph-state-2.png" id="state-2" class="update-path graph"
              alt="Graph depicting changes in eGFR over time at a loss of 3 mL/min/1.73 m2 per year" />
            <img src="./assets/images/profiles/mark/section-5-graph-state-3.png" id="state-1" class="update-path graph"
              alt="Graph depicting changes in eGFR over time at a loss of 2 mL/min/1.73 m2 per year" />
          </div>
          <div class="mobile-only">
            <img src="./assets/images/profiles/mark/mobile/section-5-graph-state-0-mobile.png" id="0" class="update-path mobile-graph graph"
              alt="Graph depicting changes in eGFR over time" />
            <img src="./assets/images/profiles/mark/mobile/section-5-graph-state-1-mobile.png" id="state-3" class="visible update-path mobile-graph graph"
              alt="Graph depicting changes in eGFR over time at a loss of 5 mL/min/1.73 m2 per year" />
            <img src="./assets/images/profiles/mark/mobile/section-5-graph-state-2-mobile.png" id="state-2" class="update-path mobile-graph graph"
              alt="Graph depicting changes in eGFR over time at a loss of 3 mL/min/1.73 m2 per year" />
            <img src="./assets/images/profiles/mark/mobile/section-5-graph-state-3-mobile.png" id="state-1" class="update-path mobile-graph graph"
              alt="Graph depicting changes in eGFR over time at a loss of 2 mL/min/1.73 m2 per year" />
          </div>

          <div class="hotspot" id="state-1" data-value="Annual eGFR loss: -2 mL/min/1.73 m^2/year"></div>
          <div class="hotspot" id="state-2" data-value="Annual eGFR loss: -3 mL/min/1.73 m^2/year"></div>
          <div class="hotspot" id="state-3" data-value="Annual eGFR loss: -5 mL/min/1.73 m^2/year"></div>

          <div class="upper-hotspots">
            <div class="hotspot lower-hotspot" id="state-3" data-value="Annual eGFR loss: -5 mL/min/1.73 m^2/year"></div>
            <div class="hotspot lower-hotspot" id="state-2" data-value="Annual eGFR loss: -3 mL/min/1.73 m^2/year"></div>
            <div class="hotspot lower-hotspot" id="state-1" data-value="Annual eGFR loss: -2 mL/min/1.73 m^2/year"></div>
          </div>
        </div>


        <div class="footnotes">
          <p>CKD：慢性肾脏病；eGFR：估算肾小球滤过率。</p>
        </div>
      </div>

    </section>

    <section class="switch-pat-section" data-section-name="Switch Patient">
      <h2 class="yellow-header">选择另一名虚拟患者</h2>

      <div class="flex">
        <div class="profile nav-el" data-nav-url="progression/sarah" data-exit-url="progression/sarah">
          <img src="./assets/images/profiles/sarah-profile.png" class="update-path" alt="Profile image for Sarah" />
          <h3>莎拉</h3>
        </div>
        <div class="profile nav-el" data-nav-url="progression/carlos" data-exit-url="progression/carlos">
          <img src="./assets/images/profiles/carlos-profile.png" class="update-path" alt="Profile image for Carlos" />
          <h3>卡洛斯</h3>
        </div>
      </div>

      <img src="./assets/images/or-line-graphic.png" class="or-line update-path" alt="Or" />

      <div class="button nav-el" id="discover" data-exit-url="pathogenesis/index" data-nav-url="pathogenesis/index">
        <p>探索 IgA肾病的疾病机制</p>
      </div>
    </section>

    {{> ../templates/footer-el }}

  </main>

  <script type="text/javascript" src="../static.bundle.js" charset="utf-8"></script>
</body>

</html>